Thoroughbred Labs SLU-PP-332

Thoroughbred Labs SLU-PP-332 is a Thoroughbred Labs listing of SLU-PP-332, supplied as 60 capsules per pack, each capsule stated by Thoroughbred Labs at 250 mcg on the tub's side panel and on its own product page, where the brand lists the product simply as SLU. It is supplied through the Muscle Market range for laboratory research only, is not for human consumption, and is sold to adults aged 18 and over. This page sets out what the published research on SLU-PP-332 reports, what the label documents and what it leaves out, how batch certificates are handled for Thoroughbred Labs products, and how the compound sits in UK law and in sport.

About SLU-PP-332

SLU PP 332, to give the common alternative spelling, is a synthetic compound that activates all three oestrogen-related receptors: ERR alpha, ERR beta and ERR gamma. Despite the name, these orphan nuclear receptors have nothing to do with the oestrogen receptor; in muscle and heart they control how many mitochondria cells build and how much fuel they oxidise. It came from the laboratories of Thomas Burris and John Walker, working at Saint Louis University and partner institutions, and its first full characterisation was published in 2023. It is the molecule behind recent exercise-in-a-pill headlines.

Identifier	Value
PubChem CID	5338394
CAS number	303760-60-3
Molecular formula	C18H14N2O2
Molecular weight	290.3 g/mol
Systematic name	4-hydroxy-N-[(E)-naphthalen-2-ylmethylideneamino]benzamide
InChIKey	RNZIMBFHRXYRLL-XDHOZWIPSA-N

Although it is sold beside peptides, SLU-PP-332 is a small organic molecule with no amino acids in it.

What the published research reports

The first paper, in ACS Chemical Biology in 2023, reported that the compound increased mitochondrial function in a muscle cell line and, in mice, increased the proportion of oxidative type IIa muscle fibres and treadmill endurance; the authors reported that activation of ERR alpha specifically was critical for the endurance effect. In 2024 the group followed with diet-induced obese and ob/ob mice, reporting higher energy expenditure and fatty acid oxidation, less fat mass and improved insulin sensitivity. Three of the authors of the first paper declared shareholdings in a company working on ERR-based therapeutics.

Two further mouse studies looked beyond muscle. In a 2024 Circulation paper, a Baylor College of Medicine team tested SLU-PP-332 and a second agonist, SLU-PP-915, in mice with heart failure induced by pressure overload; both compounds were associated with higher ejection fraction, less fibrosis and longer survival, and genetic experiments pointed to ERR gamma as the main mediator. One author declared a co-founder role in a company developing such compounds. In a 2023 study in the American Journal of Pathology, 21-month-old mice treated for eight weeks showed reversal of age-related albuminuria, podocyte loss and inflammatory markers in the kidney. Both are disease models in animals, not evidence about healthy people.

There is no human data of any kind, no human pharmacokinetic study, and no safety study in people. It is one of the newest compounds in this market and one of the least characterised. Nothing above is a claim about this product.

This listing

• Manufacturer: Thoroughbred Labs
• Compound: SLU-PP-332
• Form: Capsules
• Pack size: 60 capsules
• Strength: 250 mcg per capsule, the Thoroughbred Labs FACTS panel figure (panel footnote: updated 28/07/25); 15 mg per tub as labelled
• Batch certificate of analysis: shown where Thoroughbred Labs supplies one for the batch we hold

At a stated 250 mcg per capsule the tub holds 15 mg as labelled, which places it between the BioLab 100 mcg and 200 mcg listings and the 500 mcg listing on stated content per pack. Thoroughbred Labs also sells SLU-PP-332 in a two-product pack with 5-Amino-1MQ, listed separately as the Research System; each compound in it is a separate research substance, and we make no claim about using them together.

SLU-PP-332 in the UK: buying, legal status and what to check

Where the law stands

SLU-PP-332 is not a licensed medicine in the UK, has not been assessed by the MHRA, and is not an authorised food supplement. It is not a controlled drug under the Misuse of Drugs Act. No medicine containing it has been approved by any regulator, so no UK prescriber or pharmacy can supply it as a treatment, and any listing that sells it as a supplement, a slimming aid or an endurance product is describing something it cannot lawfully be. It may be sold to adults for laboratory research, which is the only basis for this listing. It is not for human consumption. In sport it is prohibited at all times under WADA section S0, covered below. Our research guide covers the wider legal picture for research compounds.

Signs of a documented listing

1. A manufacturer is named on the pack and on the page, and the UK seller can be contacted.
2. The stated strength per capsule, with its unit, appears on the label; here it is 250 mcg, printed on the tub's side FACTS panel.
3. A lot number is printed on the tub, and any certificate offered carries that same number.
4. The listing gives no directions for use, no quantities per day and no promised outcomes; research-use and 18+ terms are stated.
5. Delivery is tracked, the packaging is plain, and the returns terms are published.

How this listing measures up

The manufacturer is named, and the strength is taken from the brand's FACTS panel rather than from a guess. The certificate position depends on what Thoroughbred Labs has supplied for the batch in stock, and a certificate is shown only where one is held for that batch. The seller is named: FreeMuscle, registered in Andorra, with UK operations and dispatch in Scunthorpe. UK orders go by free tracked delivery in plain packaging, orders placed before 2pm Monday to Friday are processed the same working day, EU delivery takes 3-7 working days, and unopened items can be returned within 30 days (see delivery and returns). The UK supplier checklist goes into more detail.

Capsules compared with other forms

Searches for "SLU-PP-332 capsules" and "SLU-PP-332 injectable" ask whether form matters. No published study reports results for SLU-PP-332 given as a swallowed capsule. In a 2026 paper its developers stated that SLU-PP-332 lacks oral bioavailability, and they described a chemically distinct agonist, SLU-PP-915, as orally bioavailable in mice. How much of a capsule's content would survive digestion and absorption in any species has not been measured, so we draw no conclusion about form and effect.

Peptides face a different problem: protein-digesting enzymes in the gut break most of them down, as our article do oral peptides work explains. That argument does not transfer to SLU-PP-332, which is not a peptide; its limitation, as the developers describe it, is a lack of oral bioavailability. The hydrazone link can also be split by acid and water, a point that bears on stomach conditions and on storage alike.

The forms do differ in ways that can be measured on the bench:

• Capsules contain a weighed fill of powder, usually the active blended with an inert carrier. The quantity per capsule depends on the fill weight and the evenness of the blend, and only a content assay can check it against the 250 mcg on the label.
• Solutions are measured by volume. Their accuracy depends on the compound staying dissolved and chemically intact, and a hydrazone held in water is exposed to slow hydrolysis.

SLU-PP-332 compared with Cardarine

The related compound people search for most often next to SLU-PP-332 is Cardarine (GW-501516). Both are nuclear-receptor agonists that changed running capacity in mice, hence the shared exercise mimetic label, but their receptors, chemistry and histories differ.

Feature	SLU-PP-332	Cardarine (GW-501516)
Receptor	ERR alpha, beta and gamma	PPAR-delta
Chemical class	Acyl hydrazone	Phenoxyacetic acid with a thiazole ring
Formula and mass	C18H14N2O2, 290.3 g/mol	C21H18F3NO3S2, 453.5 g/mol
Developed by	University researchers, first paper 2023	Pharmaceutical industry, around 2000
Human studies	None	Short early-phase trials, mostly on blood lipids
Long-term toxicology	Not published	Rodent cancer findings; development stopped in 2007
WADA section	Prohibited at all times; S0 at minimum as a non-approved substance	S4, hormone and metabolic modulators

Mechanism. ERRs and PPAR-delta both belong to the nuclear receptor superfamily and both switch on genes for fat oxidation and mitochondrial capacity in muscle, but they are separate proteins with separate binding pockets. Neither compound is a variant of the other.

Evidence. Cardarine has the longer record. It reached small human trials measuring blood lipids, and its commercial development ended after long-term rodent studies found tumours in several tissues. SLU-PP-332 has a handful of mouse and cell papers and no human or long-term toxicology data at all. Fewer reported problems for the newer compound reflect how little it has been studied, not a better profile.

Regulation. In the UK both are unlicensed and may be sold only for research to adults. In sport both are prohibited at all times, under different sections of the WADA list. No study has compared the two directly, and we do not rank research compounds by effect. Its history is in what happened in Cardarine's development, and a Thoroughbred Labs GW-501516 listing is also stocked.

Reading the certificate of analysis for this product

Batches sold under the Free Muscle name are each assayed by Janoshik Analytical, an independent laboratory, and the certificate is emailed on request. Thoroughbred Labs is a third-party manufacturer, so a certificate appears here only when Thoroughbred Labs has supplied one for the exact batch on our shelf. A PDF without a batch number does not qualify, and we will not pass one off as a batch certificate. You can contact us with the product name and lot number to ask what is held for that batch. The document in this listing's gallery is one such report, commissioned by Thoroughbred Labs for batch 0725SLU: analysed on 31 October 2025, it requested a qualitative and quantitative analysis and prints a figure of 277.98 mcg for SLU-PP-332, with a QR code and a verification key, no purity percentage and no unit basis for the figure. Check your tub's batch number against 0725SLU. Fields to look for:

• Identity method. HPLC with UV detection matches a peak to a reference standard by retention time, which is indirect. LC-MS adds the mass: SLU-PP-332 has a monoisotopic mass of about 290.1, so the protonated ion should appear close to m/z 291.
• Purity as a percentage. The main peak's share of the total signal. Secondary peaks may be the other geometric isomer of the hydrazone or its hydrolysis products, the parent hydrazide and aldehyde.
• Amount per capsule. The line to set against the 250 mcg the label states. Without it, purity alone says nothing about quantity.
• Batch or lot number. It should match the number on the tub in front of you.
• Laboratory name and test date. These tell you who did the work and whether the result is recent.

Each gap has a specific meaning. With no identity line, nothing independent confirms the compound; with no content line, the 250 mcg on the label remains unmeasured; with a batch number that does not match, the document describes different material. Contact us with your lot number, and see how to read a certificate of analysis and our lab tests page for a worked example.

Detection, sport and testing

As a substance with no current approval for human therapeutic use, SLU-PP-332 falls at minimum under WADA section S0 (non-approved substances) and is prohibited at all times in sport; the list also has a section for hormone and metabolic modulators, so check the current edition for any specific entry. Anti-doping laboratories have already published in vitro work on its detection. In a 2026 study, a Los Angeles doping-control laboratory incubated the compound with pooled human liver S9 fractions and used liquid chromatography with high-resolution mass spectrometry to identify 22 metabolites, hydroxylated and glucuronide or sulfate conjugated forms among them, several of which the authors proposed as candidate targets for doping control. They noted that further work is needed to confirm the structures.

No study has measured how long SLU-PP-332 or its metabolites remain in human urine or blood, because it has never been given to people under study conditions. The correct summary is that it is detectable in principle and that no detection window has been established. Under strict liability, an athlete answers for any prohibited substance in a sample. Anyone subject to anti-doping rules should consult the current list, which WADA revises every year.

Storage, stability and handling

Thoroughbred Labs has not published stability data for these capsules, and no independent stability study of SLU-PP-332 exists, so any expiry date printed on the tub is the only stated limit. The structure of the molecule still indicates what to avoid. The hydrazone bond is the weak point: water can cleave it back to its two starting materials, and acid speeds the reaction. The extended aromatic system absorbs ultraviolet light, which can convert the molecule between its two geometric forms.

• Keep the tub sealed, in its original container, in a cool, dry and dark place with a steady temperature, away from radiators, sunlight and steamy rooms.
• A chilled tub should warm up with the lid on before opening, to avoid condensation.
• Handle opened capsules with gloves, away from food and drink.
• Store out of reach of children and pets, and dispose of unwanted material as chemical waste in line with laboratory good practice.

Glossary

• ERR alpha, beta and gamma: the three oestrogen-related receptors, nuclear receptors that regulate energy metabolism genes and do not bind oestrogen.
• Nuclear receptor: a protein inside the cell that binds a small molecule and then switches particular genes on or off.
• Agonist: a molecule that activates a receptor; a pan-agonist activates all members of a receptor family.
• Ejection fraction: the share of blood pumped out of the heart's main chamber with each beat, a standard measure in heart failure research.
• Albuminuria: albumin in the urine, used in animal and human studies as a marker of kidney damage.
• Hydrazone: a chemical group containing a carbon-nitrogen double bond attached to a second nitrogen, open to hydrolysis.
• LC-MS: separation by liquid chromatography followed by mass measurement, the firmer of the two usual identity tests.
• Section S0: the WADA category for pharmacological substances with no current approval for human therapeutic use.

About Thoroughbred Labs SLU-PP-332

On its own shop Thoroughbred Labs lists this product simply as SLU, 250mcg, 60 Capsules; the code printed on the tub is SLU-PP-332. The brand sells only through thoroughbredlabs.co.uk, a UK site priced in pounds, and gives 24/7 Billing Limited as its statutory business (company number 14990140; Companies House: active, London registered office, incorporated July 2023). Its menu divides the range into research peptides in vials, encapsulated compounds and Research Systems; SLU-PP-332 appears as capsules and in a Research System with 5-AMINO-1MQ, both of which we stock.

The side FACTS panel gives SLU-PP-332 250mcg per capsule, names organic rice flour and magnesium stearate as the other ingredients in a vegetarian capsule, and carries a footnote that the panel was updated on 28/07/25, so tubs printed before that date may show an earlier version. Among the brand's capsule products, only this one and BPC157 had a content report on its certificate page when we checked on 2 October 2026; the page lists SLU-PP-332 Capsules, batch 0725SLU, and the report, commissioned by the brand from an independent laboratory, is in this listing's gallery. It prints a content figure for SLU-PP-332 and no purity percentage, and the brand says each certificate covers only the batch named on it.

In our SLU-PP-332 collection this 250 mcg tub sits beside BioLab's 100, 200 and 500 mcg capsules, all 60-capsule packs, so the stated content per tub runs from 6 mg to 30 mg with Thoroughbred Labs at 15 mg. Labelling for the whole range is described in the Thoroughbred Labs collection. Check a tub by matching its batch number to 0725SLU, or asking us for the document for a later batch, confirming the shrink seal and reading the panel against this page.

SLU-PP-332 is a synthetic agonist of the oestrogen-related receptors with mouse and cell data only, first characterised in 2023; it holds no licence anywhere, is neither medicine nor food in the UK, and WADA's section S0, non-approved substances, prohibits it at all times. Here it is offered to adults for laboratory research alone.

Related

• All brands of SLU-PP-332 we stock, compared
• All Thoroughbred Labs products
• SLU-PP-332 and 5-Amino-1MQ: research guide
• 5-Amino-1MQ collection and Cardarine collection
• Batch testing and certificates of analysis
• Delivery and returns

Research compounds sold by Free Muscle are supplied for laboratory research use only and are not for human consumption. They are not authorised as medicines by the MHRA, EMA or FDA, are not food supplements, and are sold only to adults aged 18 or over. Nothing on this page is medical or dosing advice. Summaries of published research describe study findings and are not claims about any product.

References

1. Billon C, et al. Synthetic ERRalpha/beta/gamma Agonist Induces an ERRalpha-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chem Biol. 2023;18(4):756-771. PMID: 36988910.
2. Billon C, et al. A Synthetic ERR Agonist Alleviates Metabolic Syndrome. J Pharmacol Exp Ther. 2024;388(2):232-240. PMID: 37739806.
3. Xu W, et al. Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. Circulation. 2024;149(3):227-250. PMID: 37961903.
4. Wang XX, et al. Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney. Am J Pathol. 2023;193(12):1969-1987. PMID: 37717940.
5. Avliyakulov NK, et al. Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRalpha/beta/gamma Agonist for Doping-Control Purposes. Drug Test Anal. 2026;18(3):439-450. PMID: 41688415.
6. Billon C, et al. An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity. J Pharmacol Exp Ther. 2026;393(1):103787. PMID: 41421047.